𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fifteen years of Env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1

✍ Scribed by Bernd Kupfer; Tobias Sing; Peter Schüffler; Rabea Hall; Ralf Kurz; Astrid McKeown; Karl-Eduard Schneweis; Wolfgang Eberl; Johannes Oldenburg; Hans H. Brackmann; Jürgen K. Rockstroh; Ulrich Spengler; Martin P. Däumer; Rolf Kaiser; Thomas Lengauer; Bertfried Matz


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
274 KB
Volume
79
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The study of the evolution of human immunodeficiency virus type 1 (HIV‐1) requires blood samples collected longitudinally and data on the approximate time point of infection. Although these requirements were fulfilled in several previous studies, the infectious sources were either unknown or heterogeneous genetically. In the present study, HIV‐1 env C2V3C3 (nt 7029‐7315) evolution was examined retrospectively in a cohort of hemophiliacs. Compared to other cohorts, the area of interest here was the infection of six hemophiliacs by the same virus strain, that is, the infecting viruses shared an identical genome. As expected, divergence from the founder sequence as well as interpatient divergence of the predominant virus strains increased significantly over time. Based on the V3 nucleotide sequences, CCR5 usage was predicted exclusively throughout the whole period of infection in all patients. Interestingly, common patterns of viral evolution were detected in the patients of the cohort. Four amino acid substitutions within the V3 loop emerged and persisted subsequently in five (positions 305 and 308 of the HXB2 gp120 reference sequence) and six patients (positions 325 and 328 in HXB2 gp120), respectively. These common changes within the V3 loop are likely to be enforced by HIV‐1 specific immune response. J. Med. Virol. 79:1729–1739, 2007. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


High specificity of V3 serotyping among
✍ Polly R. Walker; Tonie Cilliers; Isaac A. Choge; Natasha Taylor; Sarah S. Cohen; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract V3 serotyping is a technique for determining HIV‐1 genetic subtype based on the binding of antibodies from patient sera or plasma to synthetic V3 peptides derived from subtype consensus sequences. Variation in the performance of this assay has been attributed to V3 sequence heterogeneit